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Abstract Dietary flavonoid intake is associated with re-
duced risk of cardiovascular diseases, possibly by affecting
metabolic health. The relative potency of different flavo-
noids in causing beneficial effects on energy and lipid
metabolism has not been investigated. Effects of quercetin,
hesperetin, epicatechin, apigenin and anthocyanins in mice
fed a high-fat diet (HF) for 12 weeks were compared,
relative to normal-fat diet. HF-induced body weight gain
was significantly lowered by all flavonoids (17–29 %), but
most by quercetin. Quercetin significantly lowered HF-in-
duced hepatic lipid accumulation (71 %). Mesenteric adi-
pose tissue weight and serum leptin levels were
significantly lowered by quercetin, hesperetin and antho-
cyanins. Adipocyte cell size and adipose tissue inflamma-
tion were not affected. The effect on body weight and
composition could not be explained by individual sig-
nificant effects on energy intake, energy expenditure or
activity. Lipid metabolism was not changed as measured by
indirect calorimetry or expression of known lipid metabolic
genes in liver and white adipose tissue. Hepatic expression
of Cyp2b9 was strongly downregulated by all flavonoids.
In conclusion, all flavonoids lowered parameters of HF-
induced adiposity, with quercetin being most effective.
Keywords Bioactive food components  Polyphenols 
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Introduction
Fruit and vegetable consumption is regarded as protective
against cardiovascular diseases (CVD) (Estruch et al.
2013). Flavonoids in fruits and vegetables are suggested to
be responsible, at least partly, for these protective effects.
This is supported by epidemiological studies that have
shown that an increased intake of flavonoids is associated
with a reduction in CVD risk (Peterson et al. 2012).
Nowadays flavonoid supplements are widely available,
resulting in even increasing intakes of flavonoids. Elevated
circulating lipid levels, a fatty liver and obesity are asso-
ciated with a higher risk of CVD (Boden 2008; Harchaoui
et al. 2009; Scorletti et al. 2011). Previously, we have
shown that the flavonoid quercetin can lower serum lipid
levels by affecting hepatic lipid metabolism (Hoek-van den
Hil et al. 2013) and that quercetin reduced high-fat-diet-
induced body weight gain and hepatic lipid accumulation
(Hoek-van den Hil et al. 2014).
Quercetin is one of the many flavonoids in our diet and
is the major representative of the flavonoid subclass of
flavonols. Other flavonoid subclasses are flavanones, fla-
van-3-ols, flavones, isoflavones and anthocyanins, which
all are present in our diet. However, it is not known whe-
ther these flavonoids exert similar effects as quercetin on
body weight homeostasis and lipid metabolism, and if so,
whether they affect the same metabolic pathways. Human
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intervention studies with fruits or vegetables or extracts
rich in flavonols, flavanones, flavan-3-ols or anthocyanins
showed beneficial effects on CVD-related parameters such
as blood pressure, vascular function or blood lipid profiles
(Chong et al. 2010; Hooper et al. 2008; Massaro et al.
2010). Also, flavones, mostly present in herbs and cereals,
are suggested to have beneficial effects on CVD risk fac-
tors (Benavente-Garcia and Castillo 2008). Therefore, it is
interesting to compare the effects of flavonoids from dif-
ferent subclasses on CVD risk factors.
The observed potential beneficial effects of flavonoids in
humans are mostly based on studies using flavonoid-rich
foods or extracts (Kim et al. 2011; Perez-Vizcaino and
Duarte 2010). Therefore, also other components can be
responsible for the observed effects. For instance, caffeine
was presumably present in studies with green tea catechin
extracts, which could be underlying the reduction in body
weight gain (Phung et al. 2010). Functional effects of fla-
vonoids should therefore be investigated with fully char-
acterised pure compounds. Furthermore, we have shown
that effects of quercetin on body weight depended on the
percentage and/or composition of fat in the background
diet (Hoek-van den Hil et al. 2014). It is therefore impor-
tant to directly compare effects using the same diet. A
high-fat diet that induces body weight gain and hepatic
lipid accumulation seems best suited to reveal the lipid
lowering properties of flavonoids.
Flavonoids were selected from five subclasses, based on
potential CVD protective effects, and presence in food
(Benavente-Garcia and Castillo 2008; Chong et al. 2010;
Hooper et al. 2008; Manach et al. 2005; Massaro et al.
2010). In addition to quercetin (flavonol), hesperetin (fla-
vanone), epicatechin (flavan-3-ol), apigenin (flavone) and a
purified extract of mainly cyanindin-3-O-b-glucoside and
delphinidin-3-O-b-glucoside (anthocyanins) were selected.
The aim of this study was to investigate whether other
flavonoids exert similar effects as quercetin, which reduced
high-fat-induced body weight gain and hepatic lipid accu-
mulation (Hoek-van den Hil et al. 2014). To better un-
derstand the effects, we extend the assessment with
analysis of whole-body energy balance and other metabolic
health-related analyses. A comprehensive analysis of
whole-body energy balance was performed, including
quantification of parameters such as body weight gain,
faecal energy loss, energy intake and activity. Indirect
calorimetry was used to evaluate the type and rate of
substrate utilisation and energy expenditure (EE). Fur-
thermore, circulating lipids, hepatic lipid accumulation and
hepatic gene expression patterns were studied. Addition-
ally, the effects of the flavonoids on gene expression in
white adipose tissue (WAT) were assessed, together with
WAT-secreted serum leptin levels. Leptin is a peptide
hormone which regulates body weight gain.
Methods
Animals and treatments
Eighty-four male C57BL/6JOlaHsd mice (Harlan Labora-
tories, Horst, The Netherlands) were individually housed
under controlled conditions (temperature 21 C, 12 h/12 h
light–dark cycle, 55 ± 15 % humidity), with ad libitum
access to food and water. At arrival, the mice were 9 weeks
of age. During the first 5 days of a 3-week adaptation pe-
riod, mice were fed a standard Harlan chow diet, followed
by a standardised semi-synthetic normal-fat diet [NF, 10
energy% (en%) fat] with the same dietary constituents as
the intervention high-fat diet (HF, 40 en%) in which car-
bohydrates were substituted with fats (Hoevenaars et al.
2012) (Research Diets Services B.V., Wijk bij Duurstede,
The Netherlands). At the start of the 12-week intervention
period, mice were stratified based on body weight over 7
groups (n = 12), to obtain identical groups for this im-
portant parameter. Male mice were used in order to enable
comparison of outcomes with previous findings (Hoek-van
den Hil et al. 2014). One group of mice continued on NF,
while the other six groups of mice received HF with or
without supplementation of different flavonoids
(HF ? flavonoids). A subset of data of the control HF and
HF ? quercetin group were published before (body
weight, energy intake, serum quercetin levels, and serum
and hepatic lipid levels) (Hoek-van den Hil et al. 2014).
Flavonoids were added in equimolar amounts to HF
(0.01 mol/kg diet), amounts were based on our previous
results, which showed effectiveness of quercetin at this
concentration (de Boer et al. 2006; Hoek-van den Hil et al.
2013): 0.33 % (w/w) quercetin (Sigma, Zwijndrecht, The
Netherlands), 0.33 % hesperetin (Bioconnect, Huissen, The
Netherlands), 0.32 % epicatechin (Sigma), 0.29 % api-
genin (Fuzhou Corona Science & Technology Develop-
ment Co., Ltd., Fuzhou Fujian, China) and 0.5 %
anthocyanins, a purified anthocyanin extract from bilberry
and blackcurrant consisting of mainly cyanindin-3-O-b-
glucoside and delphinidin-3-O-b-glucoside (kindly pro-
vided by Medox, Polyphenols Laboratories, Sandnes,
Norway; the exact composition of this extract has been
described by Qin et al. 2009). Sufficient amounts of indi-
vidual anthocyanins were not available. Body weight and
food intake were monitored weekly. Faeces were collected
in weeks 11 and 12. One HF ? quercetin (HF ? Q)-fed
mouse was excluded from all analyses, because of a nasal
abscess. At the end of the intervention, all mice were fasted
for 2–4 h during the light phase and anesthetised by in-
halation of 5 % isoflurane using O2 as a carrier. Blood was
sampled via orbital extraction in collect serum tubes
(Greiner Bio-one, Longwood, USA) and stored at -80 C
after obtaining serum. After blood collection, mice were
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killed by cervical dislocation, and liver, epididymal and
mesenteric white adipose tissues (epiWAT and mesWAT,
resp.) were dissected, weighted and snap frozen in liquid
nitrogen and stored at -80 C. The experiment was per-
formed according to the Dutch Animal Experimentation
Act (1996), and the experimental protocol was approved by
the Animal Welfare Committee of Wageningen University,
Wageningen, The Netherlands (DEC 2011079).
HPLC analysis of flavonoid levels in serum and diet
Flavonoid levels in serum were measured using HPLC with
coulometric array detection as described (Hoek-van den
Hil et al. 2013). Anthocyanins could not be detected by our
method. Before analysis, samples were hydrolysed by b-
glucuronidase/sulphatase to obtain deconjugated flavo-
noids, resulting in total flavonoid levels being the sum of
all glucuronidated and sulphated conjugates, while the
methylated conjugates were separately quantified. Flavo-
noid levels in the diets were also measured with HPLC to
confirm presence and stability.
Energy content of faeces and diet
Bomb calorimetry was used to determine energy content of
diet and faeces (Calorimeter C7000, IKA, Staufen, Ger-
many) as described (Hoek-van den Hil et al. 2014). Total
digestible energy intake over 12 weeks was calculated
based on weekly energy intake and faecal energy loss, by
multiplying weekly food intake by the measured dietary
gross energy content minus the extrapolated faecal energy
loss. Digestible energy intake was assumed to be compa-
rable with metabolisable energy intake, as dietary protein
content was equal for all diets and no differences in urinary
energy losses were expected.
Indirect calorimetric and activity measurements
Indirect calorimetry and activity were measured in weeks
1, 5 and 11. Indirect calorimetry was performed by an
open-circuit LabMaster Metabolism Research Platform
(TSE systems GmbH, Bad Homburg, Germany) and anal-
ysed as described previously (Hoevenaars et al. 2013) with
minor adaptations. A reference cage was measured, and
then, rates of oxygen consumption (VO2) and carbon
dioxide production (VCO2) were measured during 1 min
every 12 min for 48 h, of which the last 24 h were used. To
avoid any influence of initial stress and adaptation, only the
data of the last 24 h of a 48-h measurement were used for
analysis. Respiratory exchange ratio (RER) is defined as
VCO2 divided by VO2, and EE was calculated using the
equation [3.815 ? (1.232 9 RER)] 9 VO2 (Mclean and
Tobin 1987). Carbohydrate and lipid oxidation rates were
calculated using (Peronnet and Massicotte 1991). During
indirect calorimetry measurements, activity was con-
tinuously measured with the ActiMot system (TSE systems
GmbH) in eight cages. Infrared beam breaks in horizontal
plane (x and y direction) over the last 24 h of a 48-h period
were used.
Motor performance
Balance and motor coordination was assessed by Rotarod
(IITC Life Science, Woodland Hills, USA) in week 9.
Latency to fall was recorded on an accelerating rod
(3–38 rpm in 300 s); mice were placed on the rod four
times with an inter trial rest period of 30 min; and the
average of two longest runs per animal were used for
analysis.
Several parameters of gait were assessed in week 10 by
CatWalk analysis (Noldus Information Technology, Wa-
geningen, The Netherlands) using the reflection of light
projected on a glass walking area. Each mouse made at
least six compliant runs, being defined as a maximum
speed variation of 40 %, minimum run duration of 0.5 s
and maximum run duration of 10 s. Quantitative gait pa-
rameters were analysed using the CatWalk XT 10.0 soft-
ware (Noldus Information Technology).
Lipid determination in serum and liver
Because flavonoids were previously shown to interfere
with commonly used commercially available enzymatic
lipid assays (Hoek-van den Hil et al. 2012), alternative
methods were used to measure the amount of lipids in
serum and liver, as described (Hoek-van den Hil et al.
2013). Serum lipids were extracted and analysed with 1H
nuclear magnetic resonance (1H-NMR), and neutral lipids
were stained in frozen liver sections with Oil red O (Sigma)
and quantified.
RT-qPCR
RNA from liver was isolated using RNeasy columns
(Qiagen, Venlo, The Netherlands), RNA from epiWAT
was extracted with Trizol (Invitrogen, Breda, The Nether-
lands), and quality was verified [as published (Hoek-van
den Hil et al. 2013; Hoek-van den Hil et al. 2014)]. RT-
qPCR was performed and analysed as described [6]. Data
were normalised using reference genes beta-2 mi-
croglobulin (B2m) and hypoxanthine phophoribosyltrans-
ferase 1 (Hprt1) for liver and Hprt1 and Ribosomal protein
S15 (Rps15) for epiWAT, chosen based on stable gene
expression levels as determined with GeNorm (GeNorm,
Ghent University Hospital, Ghent, Belgium). Primer se-
quences can be found in Supplementary Table S1.
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Serum leptin levels
Serum leptin levels were determined using a leptin ELISA
kit (Crystal Chem Inc., Chicago, IL, USA) according to the
manufacturer’s instructions.
Histology of epididymal white adipose tissue
Paraffin-embedded epididymal white adipose tissue (epi-
WAT) was cut into 5-lm sections and stained using Peri-
odic Acid Schiff Haematoxylin (PASH). Per animal,
circumference of at least 400 adipocytes was measured
using AxioVision software v4.8 (Carl Zeiss Microscopy
GmbH, Jena, Germany). To estimate macrophage infiltra-
tion as a marker for tissue inflammation, a MAC-2 staining
was performed and analysed as published (Hoevenaars
et al. 2014). Macrophage infiltration is expressed as total
number of crown-like structures (CLS) per 100 adipocytes;
CLS are formed by macrophages around dying or dead
adipocytes.
Statistical analysis
All statistical analyses were in principle done based on
all 12 mice per group with the following exceptions:
HF ? Q only for 11 mice; for indirect calorimetry
measurements (n = 9), histological stainings (n = 6),
faeces collection (n = 4) and serum flavonoid measure-
ments (n = 6), subsets of mice as indicated between the
brackets were randomly selected, because of limited
equipment or practical reasons. GraphPad Prism version
5.03 (GraphPad software, San Diego, CA, USA) was
used for statistical analysis. Data were checked for nor-
mality and if needed log transformed (Acot3, Cyp4a14,
Por, Fasn and Cyp2b9 in liver and Cpt1a in EpiWAT).
One-way ANOVA was used to compare the groups,
followed by Dunnett’s post hoc test to compare the
different HF ? flavonoid groups to HF, and HF to NF.
For the analysis of data of liver weight, hepatic gene
expression of Acacb and Cpt1a, and WAT gene ex-
pression of Pparg, a Kruskal–Wallis test was used, be-
cause also after log transformation these data were not
normally distributed. Curve fitting was used to analyse
body weight gain during the 12-week intervention period
using PROAST software (Slob 2002). Two-way ANOVA
(no repeated measures) was used for analysis of the lipid
profiles in serum and for 24-h indirect calorimetry data
in time. Pearson correlation analyses were performed
using all HF ? flavonoids groups and HF group. NF was
excluded for these correlation analyses, to avoid false-
positive strong correlations due to NF. p values smaller
than 0.05 were considered significantly different.
Results
Flavonoid quantification in diets and serum
Flavonoids in the diets were measured at the start of the
experiment and were between 87 and 99 % of the theore-
tical amounts. After 1 week at room temperature in the
cages, contents of flavonoids in the diets did not change
and varied between 90 and 100 % of the theoretical fla-
vonoid amounts (Supplementary Table S2).
After 12 weeks on the HF ? quercetin diet (HF ? Q),
the sum of quercetin and isorhamnetin in serum was
6.5 ± 1.4 lM (Hoek-van den Hil et al. 2014). After the
HF ? hesperetin diet (HF ? H), hesperetin was detectable
in half of the measured serum samples (with a detection
limit of 150 nM), for which the mean concentration was
0.5 ± 0.8 lM. Epicatechin and apigenin were not de-
tectable in serum of HF ? epicatechin (HF ? E) and
HF ? apigenin (HF ? Ap) mice (with detection limits of
300 nM).
Body weight, metabolisable energy intake and feed
efficiency
Body weight was significantly increased due to HF com-
pared with NF feeding during the whole intervention pe-
riod, with a cumulative body weight gain of HF mice being
four times higher than the weight gain of NF mice (Fig. 1).
Supplementation of HF with any of the flavonoids
(HF ? flavonoids) reduced the body weight gain sig-
nificantly, as analysed by curve fitting analysis (Fig. 1a).
Cumulative body weight gain over 12 weeks was for
HF ? Q mice 29 % lower (p\ 0.001) (Hoek-van den Hil
et al. 2014) and for HF ? H mice 21 % lower (p\ 0.05)
than for HF mice (Fig. 1b). The cumulative metabolisable
energy intake over 12 weeks was not significantly different
for all HF ? flavonoid groups compared with HF, but it
was significant different for HF versus NF (Fig. 1c). As a
result, feed efficiency was significant lower for HF ? Q,
HF ? H and NF compared with HF (Fig. 1d). The calcu-
lated flavonoid intake based on the food intake of the fla-
vonoid-fed mice was for quercetin *350 mg/kg bw/day,
for hesperetin *320 mg/kg bw/day, for epicatechin
*300 mg/kg bw/day, for apigenin *500 mg/kg bw/day
and for anthocyanins *500 mg/kg bw/day.
Indirect calorimetry and activity
Respiratory exchange ratio (RER) and EE were not sig-
nificantly different between any HF ? flavonoid group and
HF in week 11, the 24-h patterns are shown in Fig. 2a, b.
Mean 12-h light- and dark-phase RER and EE values are in
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Supplementary Table S3. Mean RER values varied from
0.84 to 0.87, which implies that 48.3–58.5 % of the energy
comes from glucose oxidation and 51.7–41.5 % from fat
oxidation. HF mice had a significant lower RER compared
with NF, which is caused by the lower carbohydrate and
higher fat levels present in HF. EE was not significant
different between HF and NF mice. HF mice were sig-
nificantly less active during the dark phase compared with
NF mice. No differences were observed for activity of
HF ? flavonoids groups compared with HF during the
dark phase as well as the light phase (Fig. 2c). RER, EE
and activity for weeks 1 and 5 were all comparable to those
of week 11 (Supplementary Figure S1).
Motor performance
HF mice performed significantly poorer on the Rotarod
than NF mice, likely due to their higher body weight.
Performance on Rotarod was, however, not significantly
different between any HF ? flavonoid group and HF
(Supplementary Figure S2). There were also no significant
differences between the HF ? flavonoid groups and HF in
the measured gait parameters (Supplementary Table S4);
however, some parameters showed significant differences
between HF and NF, also likely related to the large body
weight differences.
Serum lipids
HF significantly induced higher levels of ‘MUFA and
PUFA’, ‘PUFA’, ‘18:2 fatty acids’, ‘18:1 and 16:1 fatty
acids’ and ‘omega 3 fatty acids’ in serum compared with
NF. No significant differences between HF and HF ? fla-
vonoid were observed in the serum lipid levels; however,
some of the flavonoids showed a small trend towards the
levels found for NF (Fig. 3a).
Hepatic lipid accumulation
HF feeding significantly induced hepatic lipid accumula-
tion as is apparent from an increase in liver weight
(Fig. 3b), area of lipids (Fig. 3c) and lipid droplet number
(Fig. 3d) compared with values for NF feeding. Liver
weight was not affected by the flavonoid supplementations
to the diets. Only supplementation with quercetin
(HF ? Q) significantly reduced the HF-induced lipid
A
B C D
Fig. 1 Flavonoids reduce HF-
induced body weight gain and
feed efficiency. Body weight of
the mice during 12 weeks on a
normal-fat diet (NF, 10 en% fat)
or a high-fat diet (HF, 40 %)
with or without supplementation
of the flavonoids quercetin
(HF ? Q), hesperetin
(HF ? H), epicatechin
(HF ? E), apigenin (HF ? Ap)
or anthocyanins (HF ? An) (a).
Total body weight gain over
12 weeks (b). Total
metabolisable energy intake
over 12 weeks (c). Total food
efficiency, which is the ratio of
body weight gain over
metabolisable energy intake (d).
Data are presented as
mean ± SEM. Asterisk
indicates a significant difference
of HF ? flavonoid to HF
(p\ 0.05), **p\ 0.01,
***p\ 0.001, hash indicates a
significant difference of HF to
NF (p\ 0.05), ###p\ 0.001
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accumulation. As compared to HF, quercetin lowered the
area of lipids by 71 %, and the lipid droplet number by
31 %. Representative pictures of hepatic lipid stainings are
presented in Fig. 3e.
Hepatic gene expression
Hepatic expression levels of genes involved in fatty acid
omega-oxidation were studied based on our previous ob-
servations that quercetin supplementation to a mild high-fat
(30 en%) diet induced this pathway in liver (Hoek-van den
Hil et al. 2013). HF feeding compared with NF revealed
significant induction of omega-oxidation by regulation of
Acot3, Cyp4a10 and Cyp4a14. However, no significant
regulation of these genes, nor Por was observed in any of
the HF ? flavonoid groups compared with HF (Table 1).
Subsequently, also other genes involved in lipid metabolism
were studied. Acacb and Ppargc1a were significantly
regulated by HF versus NF. However, Acacb, Fasn, Cpt1a,
Ppara and Ppargc1awere not significantly different for any
of the HF ? flavonoid diets compared with HF (Table 1).
Cyp2b9, a target gene of the transcription factor Con-
stitutive Androgen Receptor (CAR also known as NR1I3),
was strongly upregulated by HF versus NF. Interestingly,
this gene was significantly lower expressed upon supple-
mentation of HF with all of the flavonoids (FC between
-5.9 and -9.1, Table 1). Cyp2b9 expression levels for all
groups are shown in Fig. 3f.
Gene expression in white adipose tissue
Based on the above-described results, it was decided to
study gene expression in epiWAT only for NF, HF,
HF ? Q and HF ? H groups. Genes were selected by their
functions related to lipid metabolism. This showed sig-
nificant regulation of Fasn, Cpt1a, Ppargc1a, Pnpla2 and
Lep due to HF compared with NF feeding. Lep gene ex-
pression showed significant downregulation for HF ? Q
and HF ? H mice compared with HF. No significant
regulation by quercetin or hesperetin was observed for the
other genes (Table 2).
White adipose tissue and leptin
HF feeding significantly induced relative mesWAT and
epiWAT weights compared with NF feeding. Supplemen-
tation with the flavonoids prevented this induction of
relative mesWAT weight, which was significantly lower
for HF ? quercetin, HF ? hesperetin and HF ? antho-
cyanins compared with HF (Fig. 4a). Relative epiWAT
was only significantly decreased for HF ? quercetin versus
HF (Fig. 4b). A trend for decreased relative WAT weights
was seen for most of the HF ? flavonoid diets compared
with HF, in line with their reduced body weights.
Likewise, serum leptin levels, which are known to be
correlated with total adipose tissue mass, showed sig-
nificant higher values for HF mice compared with NF mice.




Fig. 2 Whole-body RER, EE and activity levels were not affected by
flavonoid supplementation. Indirect calorimetry measurements of
24-h RER (a) and EE (b) in week 11. Activity measured during
indirect calorimetry measurements for light (12-h) and dark (12-h)
period (c). Data are presented as mean ± SEM. Double hash
indicates a significant difference of HF to NF (p\ 0.001). RER,
respiratory exchange ratio; EE, energy expenditure; NF, normal-fat
diet; HF, high-fat diet; HF ? Q, HF supplemented with quercetin;
HF ? H, hesperetin; HF ? E, epicatechin; HF ? Ap, apigenin;
HF ? An, anthocyanins
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HF significantly lowered serum leptin levels compared
with HF (Fig. 4c), which also corresponds to the gene
expression results of Lep.
Adipocyte size (Fig. 4d) and macrophage infiltration
(Fig. 4e) in epiWAT were determined, and representative
pictures of adipocyte stainings are shown in Fig. 4f. Mean
adipocyte size was significantly higher for HF mice versus
NF mice. Remarkably, supplementation of flavonoids to
the HF diet did not significantly affect the HF-induced
increased adipocyte size, indicating that the lower observed
WAT weights were not due to smaller adipocytes; conse-
quently, the number of adipocytes should be decreased.
MAC-2 staining as a marker of macrophage infiltration
of epiWAT revealed no indication for inflammation (Mu-
rano et al. 2008) for all groups.
Correlations
Pearson correlations between all parameters measured
showed significant correlations between body weight gain
and all parameters for HF and all HF ? flavonoid groups
(Fig. 5a), except for the indirect calorimetry measurements
(RER and EE). Strongest correlation was found between
body weight gain and leptin (r = 0.94, p\ 0.0001,
Fig. 5b). Interestingly, Cyp2b9 expression showed also a
strong correlation (p\ 0.001) with body weight gain
(Fig. 5c), metabolisable energy intake, relative weights of
epiWAT and mesWAT, and with serum leptin levels. The
correlation plots shown in Fig. 5b, c indicate quercetin as
most potent flavonoid to modify the HF-induced effects in




Fig. 3 Effects of flavonoids on HF-induced effects on serum lipids,
liver weight and hepatic lipid accumulation. Serum lipid fractions are
shown as ratio of HF ? flavonoid or NF over the average value of the
HF control (a). Liver weight at the end of the dietary intervention of
12 weeks (b). Quantification of total area of lipids per picture (c) and
mean lipid droplet number per picture (d) in liver. Representative
pictures of stained hepatic lipids by Oil red O (e). Hepatic Cyp2b9
expression (f). Data are presented as mean ± SEM. Asterisk indicates
a significant difference of HF ? flavonoid to HF; hash indicates a
significant difference of HF to NF (p\ 0.05); ##p\ 0.01. PUFA,
poly unsaturated fatty acids; MUFA, mono unsaturated fatty acids;
FA, fatty acids; TG, triglycerides; PGLY, phosphoglycerides; PC,
phosphatidylcholine; EC, esterified cholesterol; TC, total cholesterol;
NF, normal-fat diet; HF, high-fat diet; HF ? Q, HF supplemented
with quercetin HF ? Q; hesperetin, HF ? H; epicatechin, HF ? E;
apigenin, HF ? Ap; anthocyanins, HF ? An
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Discussion
As expected, HF (40 en% fat) induced adiposity, as seen by
body weight gain, more visceral adipose tissue and hepatic
lipid accumulation, compared with NF (10 en% fat). We
examined whether this unfavourable change could be pre-
vented by individual supplementation of HF with five
different flavonoids: quercetin, hesperetin, epicatechin,
apigenin or anthocyanins. All flavonoids reduced HF-in-
duced body weight gain and hepatic Cyp2b9 expression.
Quercetin was the most potent flavonoid in beneficially
affecting the HF-disturbed whole-body energy balance and
lipid handling. In addition to quercetin, also hesperetin and
anthocyanins decreased relative mesWAT weights and
serum leptin levels. None of the flavonoids affected energy
intake, substrate use and energy expenditure.
The reduced body weight gain by all flavonoids was not
caused by reduced intake of metabolisable energy. As an
example, for HF ? quercetin-fed mice metabolisable in-
take was marginally lower than for HF mice, but this dif-
ference can only explain a lower body weight of *0.5 g,
based on the observed feed efficiency, instead of the ob-
served reduction of 4.6 g after 12 weeks. Also activity and
energy expenditure measurements in weeks 1, 5 and 11 of
the intervention showed no differences between the
HF ? flavonoid groups and HF and could therefore not
Table 1 Hepatic gene
expression (RT-qPCR)
Gene symbol HF HF ? Q HF ? H HF ? E HF ? Ap HF ? An
versus NF versus HF
Lipid omega-oxidation
Acot3 2.67## 1.07 -1.07 1.07 1.16 1.05
Cyp4a10 2.06## -1.09 1.15 1.05 -1.12 1.05
Cyp4a14 2.39### 1.11 1.23 1.09 1.06 1.04
Por 1.34 1.08 1.14 1.12 1.07 1.02
Lipid metabolism
Acacb -1.76## 1.07 1.01 1.11 -1.10 1.12
Fasn -1.10 1.10 1.05 1.17 -1.05 1.02
Cpt1a 1.25 -1.06 1.05 -1.02 -1.12 -1.01
Ppara 1.29 -1.07 1.09 1.02 -1.09 1.01
Ppargc1a -1.51## -1.06 1.05 1.10 1.18 -1.09
CAR target
Cyp2b9 40.60### -8.22*** -8.02*** -5.85** -6.33** -9.05***
Data are presented as mean fold change of HF versus NF and HF ? flavonoids versus HF
NF, normal-fat diet; HF, high-fat diet; HF supplemented with quercetin, HF ? Q; hesperetin, HF ? H;
epicatechin, HF ? E; apigenin, HF ? Ap; anthocyanins, HF ? An
## Indicates significant difference of HF to NF (p\ 0.01), ###p\ 0.001, ** indicates a significant dif-
ference of HF ? flavonoid to HF (p\ 0.01), *** p\ 0.001
Table 2 Gene expression in
white adipose tissue
Gene symbol Function HF HF ? Q HF ? H
versus NF versus HF
Fasn Fatty acids synthesis -4.19### 1.05 -1.18
Cpt1a Fatty acid beta-oxidation 1.83### -1.32 -1.22
Ppargc1a mitochondrial biogenesis -2.13### 1.10 -1.10
Lipe Lipolysis -1.10 1.02 -1.05
Pnpla2 Lipolysis -1.66### 1.27 1.14
Lep Leptin 5.80### -1.70*** -1.52**
Pparg Adipocyte differentiation -1.48 -1.00 -1.14
Clmp Adipocyte differentiation 1.25 -1.13 -1.20
Data are presented as mean fold change of HF versus NF and HF ? flavonoids versus HF
NF, normal-fat diet; HF, high-fat diet; HF ? Q, HF supplemented with quercetin; HF ? H, hesperetin
### Indicates significant difference of HF to NF (p\ 0.001), ** indicates a significant difference of
HF ? flavonoid to HF (p\ 0.01), *** p\ 0.001
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explain the differences in final body weight. These results
correspond with previous data which showed that changes
in energy expenditure could not explain weight differences
due to quercetin supplementation in mice (Henagan et al.
2014; Stewart et al. 2008). Overall, energy intake, energy
demand or energy loss were not different between the
HF ? flavonoid groups and the HF control group and
therefore cannot explain the flavonoid-induced body
weight differences.
The flavonoid-induced body weight differences could
neither be explained by an increase in lipid oxidation, as
suggested earlier (Hoek-van den Hil et al. 2013; Jung et al.
2013). Our indirect calorimetry measurements showed no
indication for differences in substrate use between the
different HF ? flavonoid groups and HF. There was no
lowering of the RER value, which would indicate increased
fatty acid versus glucose oxidation. This confirms an earlier
observation for quercetin supplementation showing an ab-
sence of effects on RER values (Stewart et al. 2008). Also
serum lipid fractions were not significantly changed by the
flavonoids; only some lipid fractions showed a small ten-
dency to decrease into the direction of values observed for
NF mice. Furthermore, except Cyp2b9, all studied lipid
metabolism genes, in liver and WAT for any of the fla-
vonoid supplementations showed no significant differences
in expression levels compared with HF. This indicates that
the flavonoids did not induce measurable changes in lipid
metabolism, which therefore cannot serve as an explana-
tion for the observed body weight differences.
Since individual parameters alone cannot explain the
effect of the flavonoids on HF-induced increases in body
weight, this effect may possibly be explained by several
smaller changes that cumulatively contribute to the total
body weight balance. Besides reduction in body weight
gain, also lowering of serum leptin levels and relative
mesenteric adipose tissue weights was found by supple-
mentation of quercetin, epicatechin and anthocyanins. We
therefore analysed to which extent the various parameters
measured were correlated with each other. Body weight
gain, WAT weights and leptin levels were strongly corre-
lated (Fig. 5, R[ 0.85, p\ 0.001). Also, significant cor-
relations were found for metabolisable energy intake and
serum leptin levels. Furthermore, also on tissue level, WAT
percentages, adipocytes area, hepatic lipid accumulation
and hepatic Cyp2b9 expression correlated with many of the
measured parameters, including body weight gain. In
contrast, energy expenditure or RER were not correlated
with body weight gain. Overall, these correlation analyses
confirm that energy expenditure and lipid oxidation alone





Fig. 4 Effects of flavonoids on
HF-induced effects on white
adipose tissue weights, serum
leptin levels, adipocyte size and
crown-like structures in
epiWAT. Mesenteric white
adipose tissue (mesWAT, a) and
epididymal tissue (epiWAT, b)
relative weight (gram/gram
body weight) at the end of the
dietary intervention. Serum
leptin levels (c). Quantification
of adipocyte sizes (d) and
crown-like structures (CLS) by
macrophage staining (e) in
epiWAT. Representative
pictures of adipocyte stainings
(f). Data are presented as
mean ± SEM. Asterisk
indicates a significant difference
of HF ? flavonoid to HF
(p\ 0.05); **p\ 0.01;
***p\ 0.001; triple hash
indicates a significant difference
of HF to NF (p\ 0.001). NF,
normal-fat diet; HF, high-fat
diet; HF supplemented with
quercetin, HF ? Q; hesperetin,
HF ? H; epicatechin, HF ? E;
apigenin, HF ? Ap;
anthocyanins, HF ? An
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flavonoids. These correlations imply that several effects on
whole body level and tissue level occur, which are related
to the body weight gain differences, and these effects could
possibly cumulatively contribute to the weight lowering
effects.
It is of interest to note that whole-body energy balance
was studied throughout the experiment at several time
points. Total energy intake, which was corrected for faecal
losses, activity and energy expenditure were taken into
account, providing a comprehensive picture of whole-body
energy balance, a major strength of this study. In addition,
liver as well as white adipose tissue were investigated,
which gives an extensive overview in comparing the ef-
fects of the different flavonoids.
Additionally, the effects of flavonoid supplementations
on the motor and gait performances was studied, because
flavonoids are also suggested to have neuroprotective ac-
tions (Spencer 2009), which could lead to improved motor
performance. No improvement was observed; however,
also no indication for adverse effects on these performance
parameters was obtained.
Furthermore, we measured the presence of the flavo-
noids in the diets and in serum, which showed absorption
of quercetin and hesperetin. The other flavonoids were not
detectable in serum, which could be ascribed to their
pharmacokinetics known to include a relatively fast rate of
elimination (Hollman 1997; Janssen et al. 1998; Manach
et al. 2005).
Interestingly, hepatic Cyp2b9 transcript levels were
strongly downregulated by all flavonoids compared with
HF (p\ 0.01). Cyp2b9 and Cyp2b10 are the major mice
homologues of human CYP2B6. Biochemical analysis has
A
B C




energy intake, RER, EE, liver
weight, hepatic lipid
accumulation, Cyp2b9
expression, weight and area of
WAT and serum leptin levels
were analysed for HF and all
HF ? flavonoids groups (a).
Pearson r values are presented,
with underneath the significance
of the correlation; *p\ 0.05,
**p\ 0.01, ***p\ 0.001,
****p\ 0.0001. Correlation
plot of BW gain to leptin for
HF, HF ? flavonoids and NF
(b). Correlation plot of BW gain
to Cyp2b9 expression (log2) for
HF, HF ? flavonoids and NF
(c). Large symbols indicate the
mean of the value per group,
and small symbols indicate the
individual mice
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shown that CYP2B6 can be inhibited by anthocyanidins,
one of the flavonoids used here (Srovnalova et al. 2014).
These P450 enzymes are involved in metabolism of ex-
ogenous and endogenous compounds, such as steroid hor-
mones, prostaglandins and fatty acids. Furthermore,
Cyp2b9 is known to be regulated by the transcription factor
CAR (Honkakoski et al. 1998; Sueyoshi et al. 1999), which
we previously proposed as a possible target of quercetin
(Hoek-van den Hil et al. 2013, 2014). Importantly, HF
increased Cyp2b9 expression 40-fold compared with NF.
This strong upregulation of Cyp2b9 by HF suggests that the
amount of lipids in the diet influenced the transcription
level of Cyp2b9. In a HF dietary context, flavonoids
downregulated Cyp2b9 with fold changes ranging from 6 to
9. This decreased expression of Cyp2b9 in the various
HF ? flavonoid groups as compared to the HF group
positively correlated with reduced body weight gain, me-
senteric WAT weight, serum leptin levels and hepatic lipid
accumulation. These results suggest a relation of the effects
of flavonoids on Cyp2b9 with lipid homeostasis, which
could be possibly regulated via CAR. Overall, the reduced
Cyp2b9 transcript levels by all flavonoids indicate a rela-
tion between Cyp2b9 and the preventive effects of the
flavonoids on the HF-induced effects. This suggests that
Cyp2b9 expression can be a marker in a possible common
mode of action of the flavonoids. It is tempting to speculate
that the newly observed common effects of the flavonoids
on hepatic Cyp2b9 expression and adiposity are
mechanistically related, but this requires further investi-
gation, as is the possible impact of the polymorphic
CYP2B6 enzyme on CVD preventive lipid lowering effects
of flavonoids.
Of all studied flavonoids, quercetin showed the stron-
gest lowering effects on HF-induced parameters. Quer-
cetin not only affected most parameters, but also showed
the most prominent effects. This is supported by corre-
lation analysis (Fig. 5a). It is particularly illustrated by
the correlation plot of leptin versus body weight gain
(Fig. 5b) and of Cyp2b9 versus body weight gain
(Fig. 5c), which indicates that quercetin better prevented
the HF-induced effects resulting in values closer to those
observed for mice fed NF.
Furthermore, the strong correlation of leptin and body
weight gain for all HF ? flavonoid groups suggests that
leptin can be used as a sensitive marker for the effects on
adiposity. This is especially of interest given that leptin,
known to regulate body weight gain, can be measured
easily and rapidly in circulation. This positions leptin as a
potential practical and useful marker to quantify flavonoid
effects on HF-induced adiposity, to be used in animal as
well as human studies.
The doses of the individual flavonoids provided
*320–500 mg/kg bw/day in this study. In humans, the
estimated intake of these individual flavonoids via food is
between 0.02 (for apigenin) and 3 mg/kg bw/day (for an-
thocyanins), and supplementary intake up to 23 mg/
kg bw/day (Manach et al. 2004). The levels used in this
experiment are comparable with levels used in animal
studies; however, for further research it would be inter-
esting to elaborate if lower doses can also be effective.
We have investigated the effects of individual flavo-
noids. However, in our daily diet a mixture of flavonoids
will be present. In theory flavonoids could act in an addi-
tive or synergistic way, the latter for example due to their
influence on efflux transporters. Furthermore, the dietary
context could also influence the effects of flavonoids (Bohn
2014; Hoek-van den Hil et al. 2014).
In conclusion, a direct comparison of metabolic effects
of quercetin, hesperetin, epicatechin, apigenin and antho-
cyanins indicated that all flavonoids beneficially affected
HF-induced disturbance of whole-body energy balance and
lipid handling, with serum leptin levels as a sensitive
marker. This confirms the suggested potential of these
flavonoids in lowering CVD risk factors. Furthermore, the
reduction in hepatic Cyp2b9 transcript levels was shown
for all flavonoids. Overall, quercetin appeared to be the
most potent flavonoid in preventing HF-induced effects.
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